Evaluation of 5-fluorouracil pharmacokinetic models and therapeutic drug monitoring in cancer patients.
about
A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs.A community-based multicenter trial of pharmacokinetically guided 5-fluorouracil dosing for personalized colorectal cancer therapyInactivation of chromatin remodeling factors sensitizes cells to selective cytotoxic stress.Translational Pharmacokinetic-Pharmacodynamic Modeling and Simulation: Optimizing 5-Fluorouracil Dosing in Children With Pediatric EpendymomaAn individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups.High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells: interaction with IQ motif-containing factorsCurrent opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.In vitro-in vivo correlations: general concepts, methodologies and regulatory applications.Therapeutic drug monitoring of 5-fluorouracil.Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early-onset fluoropyrimidine toxicity.Pharmacokinetically guided algorithm of 5-fluorouracil dosing, a reliable strategy of precision chemotherapy for solid tumors: a meta-analysis.Impact of the individualization of the first-line chemotherapy for advanced colorectal cancer based on collagen gel droplet-embedded drug sensitivity test.Population Pharmacokinetic-Pharmacodynamic Modeling of 5-Fluorouracil for Toxicities in Rats.miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells.Preparation of psoralen polymer-lipid hybrid nanoparticles and their reversal of multidrug resistance in MCF-7/ADR cells.Population pharmacokinetic modelling and simulation of 5-fluorouracil incorporating a circadian rhythm in rats.Semi-physiological pharmacokinetic-pharmacodynamic modeling and simulation of 5-fluorouracil for the whole time course of alterations in leukocyte, neutrophil and lymphocyte counts in rats.A high throughput immunoassay for the therapeutic drug monitoring of tegafur
P2860
Q33837845-D5C2E492-4E6E-47A4-B997-4C62F9718BCDQ34127889-2823637F-AF86-4F48-938E-7745A44FCFC9Q34548356-CBE3430E-E74E-4B56-ACE1-3C934D18CEA5Q36805228-0514EA9F-A5FB-4B08-A073-CE9E3BC549C2Q36962398-EAF41874-1788-454E-9E92-C359B61BDA56Q37420053-FC1834D2-5135-4880-895B-CFC786FB66C9Q38241395-464F2D70-A41A-46CA-B1D5-28538624A8FCQ38541574-801FB3F4-1BC0-46A9-81C2-BB340A7E5F73Q38842633-0E23252F-BF1A-4E28-8F18-A24EAD2ECB2DQ42210747-124516BE-2583-45A7-85DB-92A7B93193CDQ42757426-FFB931BA-6B74-41EC-BDB2-E22DBB555343Q47132740-41666197-14DE-4877-8048-81CE9DF9D252Q51042376-F0DB3046-4F31-4300-A318-8B62C8973237Q52595282-FCE31F1F-21B7-40B5-A307-6E528A90DA69Q52716704-E2287067-8849-42F1-B2DB-A691E129A658Q53304985-C5CF9B9D-2FA6-4A48-BE18-4E44AF88C875Q53718916-9F0B7D6B-F2A9-414E-AE9F-93E6E6A2602EQ59260473-2C01EE1B-319A-4CF1-BE66-90A06F49CDD8
P2860
Evaluation of 5-fluorouracil pharmacokinetic models and therapeutic drug monitoring in cancer patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Evaluation of 5-fluorouracil p ...... monitoring in cancer patients.
@en
type
label
Evaluation of 5-fluorouracil p ...... monitoring in cancer patients.
@en
prefLabel
Evaluation of 5-fluorouracil p ...... monitoring in cancer patients.
@en
P2860
P356
P1433
P1476
Evaluation of 5-fluorouracil p ...... monitoring in cancer patients.
@en
P2093
André Bp van Kuilenburg
Jan Gerard Maring
P2860
P304
P356
10.2217/PGS.13.54
P577
2013-05-01T00:00:00Z